107 related articles for article (PubMed ID: 19732722)
1. Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO.
Shankaranarayanan P; Rossin A; Khanwalkar H; Alvarez S; Alvarez R; Jacobson A; Nebbioso A; de Lera AR; Altucci L; Gronemeyer H
Cancer Cell; 2009 Sep; 16(3):220-31. PubMed ID: 19732722
[TBL] [Abstract][Full Text] [Related]
2. RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo.
Bessard A; Frémin C; Ezan F; Fautrel A; Gailhouste L; Baffet G
Oncogene; 2008 Sep; 27(40):5315-25. PubMed ID: 18521085
[TBL] [Abstract][Full Text] [Related]
3. Integrities of A/B and C domains of RXR are required for rexinoid-induced caspase activations and apoptosis.
Qin S; Okawa Y; Atangan LI; Brown G; Chandraratna RA; Zhao Y
J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):25-31. PubMed ID: 18761406
[TBL] [Abstract][Full Text] [Related]
4. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Cesario RM; Stone J; Yen WC; Bissonnette RP; Lamph WW
Cancer Lett; 2006 Aug; 240(2):225-33. PubMed ID: 16271436
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis.
Nielsen R; Pedersen TA; Hagenbeek D; Moulos P; Siersbaek R; Megens E; Denissov S; Børgesen M; Francoijs KJ; Mandrup S; Stunnenberg HG
Genes Dev; 2008 Nov; 22(21):2953-67. PubMed ID: 18981474
[TBL] [Abstract][Full Text] [Related]
6. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
[TBL] [Abstract][Full Text] [Related]
7. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells.
Benoit GR; Flexor M; Besançon F; Altucci L; Rossin A; Hillion J; Balajthy Z; Legres L; Ségal-Bendirdjian E; Gronemeyer H; Lanotte M
Mol Endocrinol; 2001 Jul; 15(7):1154-69. PubMed ID: 11435615
[TBL] [Abstract][Full Text] [Related]
8. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
9. A naturally occurring rexinoid, honokiol, can serve as a regulator of various retinoid x receptor heterodimers.
Kotani H; Tanabe H; Mizukami H; Amagaya S; Inoue M
Biol Pharm Bull; 2012; 35(1):1-9. PubMed ID: 22223330
[TBL] [Abstract][Full Text] [Related]
10. In vivo and microarray analysis of rexinoid-responsive anaplastic thyroid carcinoma.
Klopper JP; Berenz A; Hays WR; Sharma V; Pugazhenthi U; Janssen J; Singh M; Bissonnette RP; Haugen BR
Clin Cancer Res; 2008 Jan; 14(2):589-96. PubMed ID: 18223235
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis.
Dai Y; Qiao L; Chan KW; Yang M; Ye J; Ma J; Zou B; Gu Q; Wang J; Pang R; Lan HY; Wong BC
Cancer Res; 2009 Jun; 69(11):4776-83. PubMed ID: 19458067
[TBL] [Abstract][Full Text] [Related]
12. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
[TBL] [Abstract][Full Text] [Related]
13. Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expression.
Klopper JP; Sharma V; Berenz A; Hays WR; Loi M; Pugazhenthi U; Said S; Haugen BR
Mol Cancer; 2009 Mar; 8():16. PubMed ID: 19267912
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
16. Clodronate-induced cell apoptosis in human thyroid carcinoma is mediated via the P2 receptor signaling pathway.
Yang DM; Teng HC; Chen KH; Tsai ML; Lee TK; Chou YC; Chi CW; Chiou SH; Lee CH
J Pharmacol Exp Ther; 2009 Aug; 330(2):613-23. PubMed ID: 19448140
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between ERK2 and RXR regulates nuclear import of transcription factor NGFI-B.
Jacobs CM; Paulsen RE
Biochem Biophys Res Commun; 2005 Oct; 336(2):646-52. PubMed ID: 16140267
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention.
Ondrey F
Clin Cancer Res; 2009 Jan; 15(1):2-8. PubMed ID: 19118026
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXRalpha and PPARgamma1.
Chan LS; Wells RA
Biochem Biophys Res Commun; 2007 Jul; 358(4):1080-5. PubMed ID: 17521607
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of "rexinoids" in cancer prevention and treatment.
Tanaka T; De Luca LM
Cancer Res; 2009 Jun; 69(12):4945-7. PubMed ID: 19509234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]